mantle cell lymphoma

Research in Review

Comparative Effectiveness Study Identifies Optimal Therapy for MCL

08/02/2017

JCP Editors

A recent study showed improved long-term survival outcomes and quality of life (QoL) for patients with mantle cell lymphoma (MCL) receiving tyrosine kinase inhibitor (TKI) therapy compared with those receiving...

A...

08/02/2017

Journal of Clinical Pathways

Research in Review

Optimal Therapy for Type of B-Cell Malignancy

08/02/2017

JCP Editors

A...

08/02/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Improves Outcomes for Patients With MCL

06/08/2017

JCP Editors

Patients with mantle cell lymphoma (MCL) have increased odds of achieving complete remission after being treated with a combination regimen, according to research presented at the 2017 ASCO Annual Meeting (June 2-6,...

...

06/08/2017

Journal of Clinical Pathways

Research in Review

Maintenance Therapy After Autologous Stem Cell Transplant Improves Survival in MCL

04/18/2017

JCP Editors

Younger patients with mantle cell lymphoma (MCL) who receive an autologous hematopoietic cell transplant after an induction regimen are more likely to prolong their survival with maintenance therapy. ----- Related...

...

04/18/2017

Journal of Clinical Pathways

Research in Review

Autologous Stem Cell Transplantation Improves Outcomes for Patients With MCL

04/11/2017

JCP Editors

Patients with mantle cell lymphoma (MCL) benefit from prolonged event-free survival (EFS) and overall survival (OS) when treated with autologous stem cell transplantation (ASCT) and total body irradiation, according...

...

04/11/2017

Journal of Clinical Pathways

Research in Review

Maintenance Therapy for MCL Improved by Targeted Drugs

04/10/2017

JCP Editors

Recent advances in targeted therapies have the potential for major impacts on treatment practices for mantle cell lymphoma (MCL), according to a recent review published in Pharmaceuticals...

Recent...

04/10/2017

Journal of Clinical Pathways